Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival

PURPOSE: Adjuvant chemotherapy is recommended after curative surgery in patients with colon cancer of high-risk stage II and stage III. However, a considerable number of patients cannot complete the scheduled adjuvant treatment for various reasons. This study investigates the hindering factors to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jieun, Yoo, Ri Na, Cho, Hyeon-Min, Kye, Bong-Hyeon, Kim, Hyung Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Surgical Oncology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942742/
https://www.ncbi.nlm.nih.gov/pubmed/36945205
http://dx.doi.org/10.14216/kjco.21002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942742/
https://www.ncbi.nlm.nih.gov/pubmed/36945205
http://dx.doi.org/10.14216/kjco.21002

Ejemplares similares